The Revised American Thyroid Association Management Guidelines 2009 for Patients with Differentiated Thyroid Cancer: an Evidence-Based Risk-Adapted Approach
- 1 August 2010
- journal article
- guideline
- Published by Elsevier BV in Clinical Oncology
- Vol. 22 (6), 472-474
- https://doi.org/10.1016/j.clon.2010.05.001
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Management of Differentiated Thyroid Cancer with Rising Thyroglobulin and Negative Diagnostic Radioiodine Whole Body ScanClinical Oncology, 2010
- ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?European Journal of Nuclear Medicine and Molecular Imaging, 2010
- Managing Patients with a Preoperative Diagnosis of AJCC/UICC Stage I (T1N0M0) Papillary Thyroid Carcinoma: East Versus West, Whose Policy is Best?World Journal of Surgery, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- The 2009 American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer: Progress on the Road from Consensus- to Evidence-Based PracticeThyroid®, 2009
- Highlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 RevisionThyroid®, 2009
- The Pros and Cons of Prophylactic Central Compartment Lymph Node Dissection for Papillary Thyroid CarcinomaThyroid®, 2009
- The HiLo Trial: a Multicentre Randomised Trial of High- versus Low-dose Radioiodine, with or without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation after Surgery for Differentiated Thyroid CancerClinical Oncology, 2008